Discounted Cash Flow Rating

Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Charles River Laboratories International, Inc. (CRL)

Services-commercial Physical & Biological Research

https://www.criver.com

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

251 BALLARDVALE ST
WILMINGTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/23/2000

Market Cap

10,445,665,071

Shares Outstanding

51,300,000

Weighted SO

51,296,804

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.3780

Last Div

0.0000

Range

161.65-275.0

Chg

0.2250

Avg Vol

643233

Mkt Cap

10445665071

Exch

NYSE

Country

US

Phone

781 222 6000

DCF Diff

14.7889

DCF

187.7211

Div Yield

0.0000

P/S

2.5616

EV Multiple

12.6975

P/FV

2.8016

Div Yield %

0.0000

P/E

24.1542

PEG

1.9801

Payout

0.0000

Current Ratio

1.5823

Quick Ratio

1.2139

Cash Ratio

0.1895

DSO

68.2261

DIO

47.2612

Op Cycle

115.4873

DPO

18.0187

CCC

97.4686

Gross Margin

0.3388

Op Margin

0.1464

Pretax Margin

0.1325

Net Margin

0.1059

Eff Tax Rate

0.1750

ROA

0.0543

ROE

0.1211

ROCE

0.0853

NI/EBT

0.7993

EBT/EBIT

0.9049

EBIT/Rev

0.1464

Debt Ratio

0.3002

D/E

0.6409

LT Debt/Cap

0.3902

Total Debt/Cap

0.3906

Int Coverage

8.5878

CF/Debt

0.3143

Equity Multi

2.1351

Rec Turnover

5.3499

Pay Turnover

20.2568

Inv Turnover

7.7230

FA Turnover

2.0388

Asset Turnover

0.5130

OCF/Share

14.5451

FCF/Share

9.4453

Cash/Share

3.4827

OCF/Sales

0.1839

FCF/OCF

0.6494

CF Coverage

0.3143

ST Coverage

233.3694

CapEx Coverage

2.8521

Div&CapEx Cov

2.8521

P/BV

2.8016

P/B

2.8016

P/S

2.5616

P/E

24.1542

P/FCF

21.4527

P/OCF

13.9095

P/CF

13.9095

PEG

1.9801

P/S

2.5616

EV Multiple

12.6975

P/FV

2.8016

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 04, 03:42 ?????? (Synchronoss)?MWC??????????????????????????????????????????Capsyl Cloud??? GlobeNewswire Inc. Mar 04, 03:42 Synchronoss Memperkenalkan Capsyl Cloud di MWC Barcelona – Solusi Cloud Pribadi Turn-Key untuk Operator Global GlobeNewswire Inc. Mar 04, 03:42 Synchronoss, MWC ??????? ??? ????? ???? ? ?? ??? ??? ???? ??? 'Capsyl Cloud' ?? GlobeNewswire Inc. Mar 04, 03:42 Synchronoss ???????????????? Capsyl Cloud – ????????????????? GlobeNewswire Inc. Mar 04, 03:42 Synchronoss dévoile Capsyl Cloud au MWC Barcelona : une solution clé en main de cloud personnel pour les opérateurs mondiaux GlobeNewswire Inc. Mar 04, 03:42 Synchronoss ? MWC Barcelona ?? Capsyl Cloud ???? – ??????????????????? GlobeNewswire Inc. Mar 04, 03:42 Synchronoss ????? ?? Capsyl Cloud ?-MWC ??????? - ????? ??? ???? ???? ?????? ???? ??????? ???????? GlobeNewswire Inc. Mar 04, 03:42 Synchronoss stellt Capsyl Cloud auf dem MWC Barcelona vor – eine sofort einsatzbereite persönliche Cloud-Lösung für globale Betreiber GlobeNewswire Inc. Mar 04, 03:42 Synchronoss melancarkan Capsyl Cloud di MWC Barcelona – Penyelesaian Awan Peribadi yang Siap Digunakan untuk Pengendali Global GlobeNewswire Inc. Dec 16, 01:00 Healthcare Analytical Testing Services Market to Surpass Valuation of USD 15.55 Billion by 2031 | SkyQuest Technology GlobeNewswire Inc. Oct 06, 23:30 Bio Pharma Buffer Market to Reach $2.4 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research GlobeNewswire Inc. Sep 05, 05:30 Global Viral Inactivation Market Size To Worth USD 1915.2 Million By 2033 | CAGR Of 11.35% GlobeNewswire Inc. Aug 18, 23:03 Omics-Based Clinical Trials Market Size Will Reach USD 68.7 Billion by 2034, at 8.9% CAGR: Prophecy Market Insights Benzinga Jun 13, 01:37 These States Could Go Fully Legal Soon & This Cannabis Company Could Win Big: A Top Stock Pick Trading Below Peers Benzinga Nov 10, 10:00 Expert Ratings for Charles River Benzinga Oct 24, 10:00 8 Analysts Have This to Say About Charles River

Revenue Product Segmentation